Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | PARP1 | P09874 | 1/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | KCNK3 | O14649 | 3/20 | 0.50 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.47 |
| ▸ | ERN1 | O75460 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29637011 | 1.00 | HPGD (0.65) | HPGDTDP1PARP1HDAC8HDAC6 | |
| SCHEMBL7406706 | 0.87 | MEN1 (0.55) | HPGDTDP1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL6675237 | 0.86 | HPGD (0.62) | HPGDTDP1PARP1HDAC8HDAC6 | |
| SCHEMBL9100257 | 0.84 | HPGD (0.61) | HPGDTDP1PARP1HDAC8HDAC6 | |
| SCHEMBL6832775 | 0.84 | HPGD (0.61) | HPGDTDP1PARP1HDAC8HDAC6 | |
| SCHEMBL1759401 | 0.83 | HPGD (0.65) | HPGDTDP1PARP1HDAC8HDAC6 | |
| SCHEMBL11913144 | 0.82 | HPGD (0.74) | HPGDTDP1PARP1HDAC8HDAC6 | |
| SCHEMBL11675937 | 0.82 | HPGD (0.62) | HPGDTDP1PARP1HDAC8HDAC6 | |
| SCHEMBL25908515 | 0.82 | HPGD (0.62) | HPGDTDP1PARP1HDAC8HDAC6 | |
| SCHEMBL3658429 | 0.81 | HPGD (0.62) | HPGDTDP1PARP1HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1409 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3175865-B1 | FUNCTIONAL PARTICLES, PROCESS TO OBTAIN THEM, AND THEIR APPLICATIONS | SMART INOVATION LDA (PT) | 2026-04-15 | — | — | EP | claimed |
| CN-107249322-B | Method for inhibiting penetration of pest repellent into skin and penetration inhibitor for inhibiting penetration of pest repellent into skin | 阿斯制药株式会社 | 2021-10-26 | — | — | CN | claimed |
| EP-3763212-B1 | ARTHROPODA REPELLENT COMPOSITION | SANDERSTROTHMANN GMBH (DE) | 2021-08-18 | — | — | EP | claimed |
| US-11013809-B2 | Sustained delivery formulations of risperidone compound | INDIVIOR UK LIMITED (GB) | 2021-05-25 | — | — | US | claimed |
| WO-2018136909-A1 | PREPARATION OF MICROPARTICLES OF AN ACTIVE INGREDIENT | SAVIOR LIFETEC CORPORATION (TW) | 2018-07-26 | — | — | WO | claimed |
| US-20180157440-A1 | INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE | INDIVIOR INC. | 2018-06-07 | — | — | US | claimed |
| US-20180020667-A1 | CHEMICAL COMPOSITIONS THAT PRESENT SYNERGIC EFFECT FOR REPELLENCY OF INSECTS IN PERSONAL HYGIENE PRODUCTS, COSMETICS FOR HUMAN USE, IN ANIMALS AND ON INANIMATE SURFACES IN GENERAL | UNIVERSAL CHEMICAL LTDA. (BR) | 2018-01-25 | — | — | US | claimed |
| EP-3272218-A1 | CHEMICAL COMPOSITIONS THAT PRESENT SYNERGIC EFFECT FOR REPELLENCY OF INSECTS IN PERSONAL HYGIENE PRODUCTS, COSMETICS FOR HUMAN USE, IN ANIMALS AND ON INANIMATE SURFACES IN GENERAL | Universal Chemical Ltda (BR) | 2018-01-24 | — | — | EP | claimed |
| US-20170225958-A1 | FUNCTIONAL PARTICLES, PRODUCTION PROCESS AND USES | SMART INOVATION, LDA (PT) | 2017-08-10 | — | — | US | claimed |
| EP-3175865-A1 | FUNCTIONAL PARTICLES, PRODUCTION PROCESS AND USES | Smart Inovation Lda (PT) | 2017-06-07 | — | — | EP | claimed |
| EP-1126822-A1 | CONTROLLED RELEASE LIQUID DELIVERY COMPOSITIONS WITH LOW INITIAL DRUG BURST | ATRIX LABORATORIES, INC. (US) | 2001-08-29 | — | — | EP | claimed |
| US-6211389-B1 | TREATING SPECIFICALLY DEFINED COMBINATIONS COMPRISING AN EPOXY RESIN STARTING MATERIAL AND OTHER COMPONENTS TO ORGANIC SOLVENT, A CROWN ETHER, AND A SUITABLE BASE TO CONDITIONS SUFFICIENT TO PRODUCE A TREATED EPOXY COMPOUND | DEXTER CORPORATION | 2001-04-03 | — | — | US | claimed |
| US-6143314-A | THERMOPLASTIC RESIN | ATRIX LABORATORIES, INC. (US) | 2000-11-07 | — | — | US | claimed |
| WO-2000038512-A1 | METHOD AND APPARATUS FOR DISPERSING A VOLATILE COMPOSITION | UNIVERSITY OF SOUTHAMPTON (GB) | 2000-07-06 | — | — | WO | claimed |
| WO-2000024374-A1 | CONTROLLED RELEASE LIQUID DELIVERY COMPOSITIONS WITH LOW INITIAL DRUG BURST | ATRIX LABORATORIES, INC. (US) | 2000-05-04 | — | — | WO | claimed |
| US-5888533-A | Non-polymeric sustained release delivery system | ATRIX LABORATORIES, INC. (US) | 1999-03-30 | — | — | US | claimed |
| EP-0525893-B1 | The use of an aqueous hard surface cleaner containing an insect repellent material | COLGATE PALMOLIVE CO (US) | 1999-02-24 | — | — | EP | claimed |
| US-5736152-A | Non-polymeric sustained release delivery system | ATRIX LABORATORIES, INC. (US) | 1998-04-07 | — | — | US | claimed |
| EP-0754064-A1 | AN ADJUNCTIVE POLYMER SYSTEM FOR USE WITH MEDICAL DEVICE | ATRIX LABORATORIES, INC. (US) | 1997-01-22 | — | — | EP | claimed |
| WO-1995028124-A2 | AN ADJUNCTIVE POLYMER SYSTEM FOR USE WITH MEDICAL DEVICE | ATRIX LABORATORIES, INC. (US) | 1995-10-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11013809-B2 | Sustained delivery formulations of risperidone compound | SLC6A3, GRIN2A, GRIN2D | HPGD 2124/4885TDP1 1172/4885PARP1 1037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.